Datum: 8.7.2008
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for the great majority of staphylococcal infections worldwide, both in hospitals and in the community.
Whole article on biovalley
Mendel Lectures: How cohesin controls sister chromatid cohesion and transcription
Mendel's refectory, Brno, Czech republic, October 09, 2008
The Tips and Tricks of Gas Chromatography for Optimum Performance
Corinthia Towers Hotel, Praha, Czech republic, October 10, 2008
TATAA open qPCR course
Instiute of Molecular Genetics, Prague, Czech republic, October 13-17, 2008
Platts Cellulosic Ethanol and Biofuels: Moving to Industrial-Scale Production
Chicago, United States, October 09-10, 2008
Bio-Venture Capital Forum
Dalian, China, October 10-15, 2008
IBS 2008 - 13th International Biotechnology Symposium & Exhibition
Dalian, China, October 12-17, 2008
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 South Moravian Innovation Centre
Interesting biotechnology content:
ScienceWeek - Biotechnology Science since 1997
Práce - Nabidky prace
Czech GM maize area tops 8,000 ha in 2008
Viral bacteria engineered to spot E. coli